title: Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
authors.forename: Ehtisham
authors.initials: E
authors.lastname: Mahmud
authors.forename: Omid
authors.initials: O
authors.lastname: Behnamfar
authors.forename: Felice
authors.initials: F
authors.lastname: Lin
authors.forename: Ryan
authors.initials: R
authors.lastname: Reeves
authors.forename: Mitul
authors.initials: M
authors.lastname: Patel
authors.forename: Lawrence
authors.initials: L
authors.lastname: Ang
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology*; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects*; D011183:Postoperative Complications / Q000097:blood* / Q000209:etiology*; D013997:Time Factors
chemical_list: D005340:Fibrinogen